Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy

Lanyu Li1, Cheng Qiu2,3, Min Hou2

  • 1Department of Obstetrics and Gynecology, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Insights

Ovarian cancer (OVCA) remains lethal due to recurrence. This review explores ferroptosis, a cell death process, as a potential new treatment strategy for ovarian cancer by examining its pathways and regulators.

Area of Science:

  • Oncology
  • Cell Death Mechanisms
  • Biochemistry

Background:

  • Ovarian cancer (OVCA) has a poor prognosis, with survival rates below 50% due to high recurrence and limited early detection.
  • Current treatments like surgery, chemotherapy, and targeted therapies are often insufficient for effective OVCA management.
  • Ferroptosis, a regulated cell death characterized by lipid peroxidation and iron dependency, presents a promising avenue for anti-cancer therapy.

Purpose of the Study:

  • To review the major pathways involved in ferroptosis.
  • To explore the foundational research connecting ferroptosis and ovarian cancer.
  • To identify potential therapeutic strategies for OVCA based on ferroptosis.

Main Methods:

  • Literature review of ferroptosis pathways and regulators.
  • Analysis of existing studies on ferroptosis in ovarian cancer.
  • Synthesis of findings to propose future research directions.

Main Results:

  • Ferroptosis is a distinct cell death pathway with significant implications for various diseases.
  • Emerging evidence suggests a link between ferroptosis and ovarian cancer development and progression.
  • Numerous ferroptosis regulators and protective pathways have been identified.

Conclusions:

  • Ferroptosis represents a novel therapeutic target for ovarian cancer.
  • Understanding ferroptosis pathways may offer new treatment strategies beyond conventional methods.
  • Further research is needed to elucidate the role of ferroptosis in OVCA and develop targeted therapies.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K